RY

Ravindra Yogesh Shenoy

Active Director Director DIN 00410124
DIN 00410124 First appointment Feb 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 7 active board seats
Past companies 8 historical roles
Total affiliations 15 Since Feb 2005
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 22 Feb 2005
Active appointments 9
Total timeline records 15

Ravindra Yogesh Shenoy (DIN 00410124) has 15 recorded board appointments in Indian companies, the first from February 2005, of which 9 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2005
Koye Endeavours Private Limited Director · 2022 – present
Current
Yeus Lifesciences Private Limited Director · 2020 – present
Current
Koye Foundation Director · 2019 – present
Current
Koyna Biologics Private Limited Director · 2016 – present
Current
Blue Oyster Enterprises Llp Designated Partner · 2015 – present
Current
Wealthurn Estates Llp Designated Partner · 2015 – present
Current
Koye Enterprises Llp Designated Partner · 2013 – present
Current
Wealthurn Enterprises Llp Designated Partner · 2013 – present
Current
Koye Pharmaceuticals Private Limited Director · 2013 – present
Current
Koye Lifesciences Private Limited Director · 2022 – 2025
Previous
Aurobindo Pharma Ltd Additional Director · 2012 – 2012
Previous
Enzene Biosciences Limited Director · 2011 – 2014
Previous
Glimmer Enterprise Private Limited Director · 2005 – 2009
Previous
Parle Industries Limited Director · 2005 – 2012
Previous
Arth Welfare Foundation Director · 2005 – 2015
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available